This is Volume 6: Nervous System Agents, of Burger's Medicinal Chemistry and Drug Discovery, 6th Edition. This new volume contains critical new chapters on Alzheimer's Disease: Search for Therapeutics, Cognition Enhancers and Drugs to Treat Eating and Body Weight Disorders. To purchase the entire 6 volume set, please refer to ISBN 0-471-37032-0. For a complete list of articles and contributors as well as FREE sample chapters from this new 6th Edition please visit: www mrw.interscience.wiley/bmcdd
Table of Contents
1. ADRENERGICS AND ADRENERGIC-BLOCKING AGENTS (Robert K. Griffith, West Virginia University, School of Pharmacy, Morgantown, West Virginia).2. CHOLINERGICS (Joseph G. Cannon, The University of Iowa, Iowa City, Iowa).3. ANTICHOLINERGIC DRUGS (B. V. Rama Sastry, School of Medicine, Vanderbilt University, Nashville, Tennessee).4. CNS STIMULANTS (David E. Nichols, Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, Indiana, West Lafayette).5. SEDATIVE-HYPNOTICS (Julius Vida, Vida International Pharmaceutical Consultants, Greenwich, Connecticut; Joseph Yevich, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, Wallingford, Connecticut).6. ANTICONVULSANTS (Kenneth R. Scott, School of Pharmacy, Howard University, Washington, DC).7. NARCOTIC ANALGESICS (Jane V. Aldrich, Sandra C. Vigil-Cruz, Department of Medicinal Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas).8. ANTIDEPRESSANTS (Leslie Iversen, University of Oxford, Department of Pharmacology, Oxford, United Kingdom; Richard A. Glennon, Virginia Commonwealth University, School of Pharmacy, Richmond, Virginia).9. ANTIANXIETY AGENTS (Kevin S. Currie, Neurogen Corporation, Branford, Connecticut).10. ANTIPSYCHOTIC AGENTS (C. Anthony Altar, Psychiatric Genomics, Inc., Department of Gene Discovery, Gaithersburg, Maryland; Arnold R. Martin, University of Arizona, Department of Pharmacology, College of Pharmacy, Tucson, Arizona; Andrew Thurkauf, Neurogen Corporation, Department of Medicinal Chemistry, Branford, Connecticut).11. INVESTIGATIVE AGENTS FOR USE IN NEURODEGENERATIVE CONDITIONS (James David Adams Jr., Department of Molecular, Pharmacology and Toxicology, USC School of Pharmacy, Los Angeles, California; Thomas F. Woolf, HyBar BioScience, LLC, Ann Arbor, Michigan).12. THERAPEUTIC AND DIAGNOSTIC AGENTS FOR PARKINSON'S DISEASE (John L. NeumeyerRoss J. Baldessarini, Harvard Medical School, McLean Hospital, Belmont, Massachusetts; Raymond G. Booth, School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina).13. ALZHEIMER'S DISEASE: SEARCH FOR THERAPEUTICS (W. Janusz Rzeszotarski, Food and Drug Administration, Rockville, Maryland).14. COGNITION ENHANCERS (Clark N. Eid, Jr., Yong-Jin Wu, Division of Central Nervous System Chemistry, Bristol-Myers Squibb, Pharmaceutical Research Institute, Wallingford, Connecticut; Gene G. Kinney, Department of Neuroscience, Merck Research Laboratories, West Point, Pennsylvania).15. DRUGS TO TREAT EATING AND BODY WEIGHT DISORDERS (Philip A. Carpino, John R. Hadcock, Pfizer Global Research & Development-Groton Labs, Department of Cardiovascular and Metabolic Diseases, Groton, Connecticut).INDEX.CUMULATIVE INDEX.
DONALD A. ABRAHAM, PhD, is Professor and Chairman of the Department of Medicinal Chemistry at the Virginia Commonwealth University School of Pharmacy. A world-renowned leader in medicinal chemistry and biotechnology, he is the author of more than 140 journal citations and twenty-five patents. He was selected by the AACP Board of Directors as the recipient of the 2002 AACP Paul Dawson Biotechnology Award.